The UAE, along with Pfizer, made the important announcement

The Department of Health has decided to work with Pfizer to enhance expertise in clinical trials and medical procedures. The biopharmaceutical company will train 150 medical researchers under the agreement.

Abu Dhabi (Urdu Point newspaper latest. December 24, 2021) In view of the resurgence of corona cases in the country, the UAE, together with Pfizer, made an important announcement. According to Emirati media, Abu Dhabi’s health department has decided to work with Pfizer to enhance expertise in clinical trials and medical procedures. The biopharmaceutical company will train 150 medical researchers under the agreement, Pfizer. The department will assist in the development of clinical trials and training curricula for advancing the early stages of drug development, which will help in the development of clinical trials in the UAE for research efforts, running and enhancing the medical process, participants said. Will also receive training in technologies and artificial intelligence devices that accelerate the process of drug discovery, aimed at achieving 500 authoritative medical researchers by 2025 through various collaborations and initiatives.
“We look forward to working with Pfizer, which focuses on conducting safe and effective early-stage clinical trials based on international guidelines and global best practices,” said Dr. Jamal Al-Kaabi, Under-Secretary of the Department. The UAE has one of the world’s most successful CoVID-19 vaccination drives, with 100% of eligible people receiving their first dose and more than 90% receiving both doses as of November, since the outbreak. As the UAE continues to provide vaccines to the public as well as participate in vaccine trials, the Department of Health last month announced the purchase of the drug AZD7442, manufactured by AstraZeneca, which poses a high risk. There is a new antibody drug to fight infection in patients with Alzheimer’s.
Dr. Al-Kaabi said that the Department of Health is committed to position Abu Dhabi as an incubator for innovation in the field of life sciences and as an important destination for healthcare in the world. Provides that encourages and encourages research and innovation in healthcare, expands the means of collaboration that engages Abu Dhabi with global partners, and promising clinical trials and research projects. Continues
Pfizer correspondent Lindsey Dietschi said: “Abu Dhabi has established a strong and sustainable healthcare system that promotes innovation in research and development. We believe in the vision of Abu Dhabi to provide more medical achievements.” And to ensure healthy communities.

Leave a Reply

Your email address will not be published. Required fields are marked *